Enbrel (Etanercept) for Psoriasis

Overview
Enbrel is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis in adults and children over age 4 and psoriatic arthritis in adults. Enbrel is also known by its drug name, etanercept.

Enbrel is a biologic drug. It is a fusion protein created by genetic engineering. Enbrel is believed to work by attaching to tumor necrosis factor alpha (TNF-α), a chemical messenger involved in autoimmune attacks. Enbrel binds to TNF-α and prevents it from signaling the immune system to attack the connective tissues.

How do I take it?
Enbrel is administered via subcutaneous injection at a frequency dependent on the condition it’s being used to treat.

Enbrel is available in multiple forms, including as a single-dose prefilled syringe, and single-dose prefilled autoinjector.

Side effects
Common side effects of Enbrel include infections and injection site reactions.

Rare but serious side effects of Enbrel include increased risk for certain types of cancer, demyelinating diseases such as multiple sclerosis, congestive heart failure, anemia, and serious allergic reactions.

For more information, visit:

Enbrel — Amgen
https://www.enbrel.com